News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Musella Foundation Co-payment Assistance Program about to close to new patients

Al's Comment:

 If you think you qualify and may need help paying for one of the covered treatments (Optune, Gliadel, Temodar or Avastin), send in the application as soon as possible. We have enough funding for only a few more patients. 


Posted on: 07/25/2016

Musella Foundation Co-payment Assistance Program about to close to new patients 

The Musella Foundation For Brain Tumor Research and Information Inc, has a program to help brain tumor patients pay for the treatments they need.  We have awarded over $3.8 million to help patients since the program started in December 2011. However, the copay assistance fund is running low and we may have to close to new patients in the next few days.  Of course, patients already approved will continue to have their claims paid until their grant expires. 

We will reopen the program as soon as we raise more funding for it.  If you would like to help by making a donation, go to virtualtrials.com/donate8.cfm and select "Co-payment assistance fund" under USAGE.  

If you need assistance with your copayments, go to http://braintumorcopays.org/ for details and to get the application.

 

 

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740